MedTrace Logo

Efficacy and Safety of Colistin Based Antibiotic Therapy

NCT04764058 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-02-21

No results posted yet for this study

Summary

To evaluate the efficacy and safety of antibiotic combinations containing Colistin in the treatment of children with multidrug-resistant gram negative infections admitted in the pediatric surgery intensive care unit.

The main outcome measure is clinical and microbiological responses to therapy.

The secondary outcome is the occurrence of adverse events during Colistin combination treatment.

Conditions

Interventions

DRUG

Tienam 500

Imipenem and cilastatin sodium

DEVICE

Infusion

Health caregivers give the drug to the patients and monitoring the infusion rate

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • AHMED S ATTIA · Heliopolis University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2019-09-01
Completion
2021-09-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04764058 on ClinicalTrials.gov